LFA-1 integrin antibodies inhibit leukocyte α4β1–mediated adhesion by intracellular signaling

M Grönholm, F Jahan, EA Bryushkova… - Blood, The Journal …, 2016 - ashpublications.org
M Grönholm, F Jahan, EA Bryushkova, S Madhavan, F Aglialoro, L Soto Hinojosa, LM Uotila…
Blood, The Journal of the American Society of Hematology, 2016ashpublications.org
Binding of intercellular adhesion molecule-1 to the β2-integrin leukocyte function associated
antigen-1 (LFA-1) is known to induce cross-talk to the α4β1 integrin. Using different LFA-1
monoclonal antibodies, we have been able to study the requirement and mechanism of
action for the cross-talk in considerable detail. LFA-1-activating antibodies and those
inhibitory antibodies that signal to α4β1 induce phosphorylation of Thr-758 on the β2-chain,
which is followed by binding of 14-3-3 proteins and signaling through the G protein …
Abstract
Binding of intercellular adhesion molecule-1 to the β2-integrin leukocyte function associated antigen-1 (LFA-1) is known to induce cross-talk to the α4β1 integrin. Using different LFA-1 monoclonal antibodies, we have been able to study the requirement and mechanism of action for the cross-talk in considerable detail. LFA-1-activating antibodies and those inhibitory antibodies that signal to α4β1 induce phosphorylation of Thr-758 on the β2-chain, which is followed by binding of 14-3-3 proteins and signaling through the G protein exchange factor Tiam1. This results in dephosphorylation of Thr-788/789 on the β1-chain of α4β1 and loss of binding to its ligand vascular cell adhesion molecule-1. The results show that with LFA-1 antibodies, we can activate LFA-1 and inhibit α4β1, inhibit both LFA-1 and α4β1, inhibit LFA-1 but not α4β1, or not affect LFA-1 or α4β1. These findings are important for the understanding of integrin regulation and for the interpretation of the effect of integrin antibodies and their use in clinical applications.
ashpublications.org